DePuy hip replacement claims
DePuy ASR Hip Recall Information
On 26th August 2010, DePuy Orthopaedics, Inc. announced a recall of the DePuy ASR (Articular Surface Replacement) Hip Resurfacing System and ASR XL Acetabular System total hip replacement. About 93,000 of these hip implants have been fitted worldwide.
Numerous patients have since required a second hip replacement surgery to correct issues associated with the DePuy devices, and thousands of actions have already been filed against the manufacturer of these devices following the onset of painful and debilitating side effects.
The DePuy ASR revisions are necessary because the device is defectively designed and manufactured so that high levels of metal ions are released from the Depuy ASR hip. This metal ion release damages tissue, causes pseudotumours, and results in osteolysis requiring hip revision surgery to remove and replace the device. This may happen shortly after the DePuy ASR hip replacement is implanted into the patient or it may take years to occur.
Data from a study conducted by the National Joint Registry of England and Wales revealed that five years following the initial implantation surgery, 12 percent of patients who were implanted with the ASR resurfacing device and 13 percent of those who received the ASR total hip replacement required a second hip replacement surgery to correct problems associated with the devices.
About 3,500 people had defective DePuy Orthopaedics hip joints fitted in Ireland in 16 public and 14 private hospitals before DePuy ordered a worldwide recall of the product in 2010.
Depuy ASR hip replacement patients may be eligible for compensation due to the injuries they have suffered as a result of being implanted with the defective DePuy ASR hip replacement. Past and future pain, suffering, medical bills, loss of earnings, and disfigurement are among the damages that patients may be entitled to recover.
The first settlements are now being made in the United States.